While the study had a large sample size and underwent manual review by experienced neuro-ophthalmologists, additional research, such as larger multicenter studies or prospective clinical trials, is required to confirm findings and explore causality
To investigate the genetic basis of this variability, here we conduct a genome-wide association study of self-reported weight loss and treatment-related side effects in 27,885 people following GLP1 receptor agonist therapy
Activation of both GIP and GLP-1 receptors by retatrutide probably contributed to the observed changes in circulating triglycerides, as treatment with the dual GIP/GLP-1 receptor agonist tirzepatide significantly reduced triglyceride levels by up to 29% at 52 weeks in a clinical trial in people with T2D and MASLD 8
However, these results come from different trial stages and designs, making a direct comparison difficult
For women navigating weight management alongside hormonal changes, the intersection of metabolic peptides and hormonal health adds another layer of complexity
The ingredients are carefully selected to help promote healthy blood sugar response, optimize nutrient utilization, and support sustainable energy throughout the day